Perspective Therapeutics, Inc. - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-11-16

Reporting Person: Vitale Philip J (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-16	Common Stock	P	100	$0.425	Acquired	40100	Direct
2017-11-16	Common Stock	P	100	$0.4251	Acquired	40200	Direct
2017-11-16	Common Stock	P	8480	$0.43	Acquired	48680	Direct
2017-11-16	Common Stock	P	200	$0.4304	Acquired	48880	Direct
2017-11-16	Common Stock	P	400	$0.4389	Acquired	49280	Direct
2017-11-16	Common Stock	P	3049	$0.438	Acquired	52329	Direct
2017-11-16	Common Stock	P	18	$0.435	Acquired	52347	Direct
2017-11-16	Common Stock	P	1400	$0.439	Acquired	53747	Direct
2017-11-16	Common Stock	P	1606	$0.44	Acquired	55353	Direct
2017-11-16	Common Stock	P	496	$0.4399	Acquired	55849	Direct
2017-11-16	Common Stock	P	300	$0.4362	Acquired	56149	Direct
2017-11-16	Common Stock	P	300	$0.4425	Acquired	56449	Direct
2017-11-16	Common Stock	P	12851	$0.45	Acquired	69300	Direct
2017-11-16	Common Stock	P	600	$0.449	Acquired	69900	Direct
2017-11-16	Common Stock	P	100	$0.444	Acquired	70000	Direct